Entelexo Biotherapeutics, Inc is an innovative biotech company based in Irvine, CA, specializing in the development of a new class of exosome-based therapeutics for autoimmune diseases. Their proprietary engineering platform allows for the rapid prototyping of therapeutics that can communicate with multiple specific types of diseased cells simultaneously, addressing the complexities associated with autoimmune diseases.
With a focus on patient analysis and data utilization, Entelexo aims to optimize product efficacy by matching the natural complexities of autoimmune diseases. Their pipeline includes the development and fine-tuning of indication-specific exosome treatments, with lead drug candidates selected and efficacy evaluated through human cell immunoassays.
Generated from the website
